Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland.
Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland.
Biomed Pharmacother. 2020 Jul;127:110196. doi: 10.1016/j.biopha.2020.110196. Epub 2020 May 12.
Pregnancy and time period right after labour are connected with some dangerous states, such as: pregnancy-induced hypertension (PIH), which afflict 6-10 % of pregnant women and mood disorders where postpartum depression occurs among 10-15 % of women after labour and so-called baby blues afflicts around 43 % of them. Scientists tried to link those diseases which afflicts thousands of women per year, and the linking factor appears to be methyldopa which is the first choice treatment of PIH. Recent study showed that 778 % of pregnant women treated with methyldopa suffered to postpartum depression. Aim of this article is to delineate mechanisms through which methyldopa induce mood disorders.
Authors reviewed following databases for randomized controlled trials and review articles published up to February 2019: Pubmed, Scopus, Google Scholar, Cochrane Database and ClinicalKey. Keywords used to research were: postpartum depression, methyldopa, depression, baby blues, pregnancy-induced hypertension, gestational hypertension, VEGF, nitric oxide, prolactin, hyperprolactinaemia. Selection of studies was based on relevance, year of publication, and reliability of methodology. Authors included every study contributory to assessment of scale of the problem of postpartum depression and baby blues, along with connection of those diseases with usage of methyldopa.
Methyldopa alterate neurotrophic factors levels, impairs cerebral blood flow, and through dopamine level reduction it impairs reward system and increase prolactin release. Moreover, methyldopa leads to catecholamines depletion which impairs neurons function and increase concentration of nitric oxide (NO) which have neurotoxic properties.
Epidemiological, as well as pharmacological studies confirmed important role of methyldopa in induction of postpartum depression and baby blues through hormone alteration, reduced cerebral blood flow and neurons function impairment. This study proves how important for women's health is this problem and how complex is its mechanism.
怀孕和分娩后时期与一些危险状态有关,例如:妊娠高血压(PIH),影响 6-10%的孕妇;产后情绪障碍,其中 10-15%的女性患有产后抑郁症;所谓的“婴儿蓝调”影响大约 43%的女性。科学家试图将这些每年影响数千名女性的疾病联系起来,而联系因素似乎是甲基多巴,它是 PIH 的首选治疗药物。最近的一项研究表明,778%接受甲基多巴治疗的孕妇患有产后抑郁症。本文的目的是阐明甲基多巴引起情绪障碍的机制。
作者在以下数据库中检索了随机对照试验和综述文章,检索截至 2019 年 2 月:PubMed、Scopus、Google Scholar、Cochrane 数据库和 ClinicalKey。用于研究的关键词是:产后抑郁症、甲基多巴、抑郁症、婴儿蓝调、妊娠高血压、妊娠期高血压、VEGF、一氧化氮、催乳素、高催乳素血症。研究的选择基于相关性、发表年份和方法的可靠性。作者纳入了每一项有助于评估产后抑郁症和婴儿蓝调问题规模的研究,以及这些疾病与甲基多巴使用之间的联系。
甲基多巴改变神经营养因子水平,损害脑血流,通过降低多巴胺水平损害奖励系统并增加催乳素释放。此外,甲基多巴导致儿茶酚胺耗竭,损害神经元功能并增加具有神经毒性的一氧化氮(NO)浓度。
流行病学和药理学研究证实,甲基多巴通过激素改变、脑血流减少和神经元功能损害在诱导产后抑郁症和婴儿蓝调方面发挥重要作用。这项研究证明了这个问题对女性健康的重要性以及其机制的复杂性。